CRL Snapshot
Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the Pharmaceutical, Medical device and Biotechnology industries. It also supplies assorted biomedical products and outsourcing services for research and development in the pharmaceutical industry and offer support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.
Market Capitalization$18,939,793,000
Price to Sales5.53
Earnings per Share$7.7200
PE Ratio48.61
Most Recent Close$375.3100
52 Week High$460.21
52 Week Low$232.82
50-Day Moving Average$409.34
200-Day Moving Average$365.63
All data are from Alpha Vantage as of today. For more infomation on CRL see Stock Dividend, Valuation, Price and Financial Data for Investors